# A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-i-clinical-trial-of-guadecitabine-and-carboplatin-in-platinum-resistant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniela Matei,Sharad Ghamande,Lynda D. Roman,Angeles Alvarez Secord,John Nemunaitis,Merry Jennifer Markham,Kenneth P. Nephew,Simone Jueliger,Aram Oganesian,Sue Naim,Xiang Yao Su,Harold Keer,Mohammad Azab,Gini F. Fleming |
| Citations | 65 |
| DOI | 10.1158/1078-0432.ccr-17-3055 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://clincancerres.aacrjournals.org/content/clincanres/24/10/2285.full.pdf |
| OpenAlex ID | https://openalex.org/W2793022348 |
| PMID | 29500276 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Xiang Yao Su](https://scholariq.org/researchers/xiang-yao-su/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.